63.67 -0.04 (-0.06%)
Pre-market: 5:39AM EST
|Bid||63.11 x 1200|
|Ask||63.67 x 1800|
|Day's range||62.81 - 64.23|
|52-week range||56.56 - 85.97|
|Beta (5Y monthly)||0.43|
|PE ratio (TTM)||650.10|
|Earnings date||28 Apr 2021 - 03 May 2021|
|Forward dividend & yield||2.84 (4.46%)|
|Ex-dividend date||12 Mar 2021|
|1y target est||74.11|
Despite some serious setbacks, this beaten-down biotech could be a terrific bargain at recent prices.
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
Diodes Incorporated (Nasdaq: DIOD) today reported its financial results for the fourth quarter and fiscal year ended December 31, 2020.